Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,559 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Benitec Biopharma Inc.Biotechnology
Hayward, California · founded 2019 · Equity, Options, Convertible · 17 investors · J. Buchi, Peter Francis
Celcuity Inc.Biotechnology
Minneapolis, Minnesota · Debt, Options, Convertible · 1 investors · Polly Murphy, Richard Buller
Iambic Therapeutics, Inc.Biotechnology
San Diego, California · founded 2019 · Equity · 7 investors · Tabbert Teng, Neil Josephson
Amicrobe, Inc.Biotechnology
Carlsbad, California · Equity, Convertible · 32 investors · Albert Carnesale, Michael Bevilacqua
Oncocyte CorpBiotechnology
Irvine, California · Equity, Options, Convertible · 21 investors · Joshua Riggs, James Liu
Amicrobe, Inc.Biotechnology
Carlsbad, California · Equity · 51 investors · Martin Burns, Albert Carnesale
NeuroSense Therapeutics Ltd.Biotechnology
Herzliya, Israel · Options, Convertible · 1 investors · Revital Mandil-Levin, Mark Leuchtenberger
Kubanda Cryotherapy, Inc.Biotechnology
Baltimore, Maryland · Debt, Options, Convertible, Convertible Note convertible into preferred stock · 1 investors · Bailey Surtees, Yixin Hu
Carterra, Inc.Biotechnology
Salt Lake City, Utah · Debt, Options · 15 investors · Janel Fillinger, Josh Eckman
Anuncia Medical, Inc.Biotechnology
Scottsdale, Arizona · Debt, Options · 28 investors · Ghassan Kassab, Elsa Abruzzo
Qlaris Bio, Inc.Biotechnology
Dedham, Massachusetts · Equity · 8 investors · Andrew Danielson, Ronald Hunt
RenovoRx, Inc.Biotechnology
Los Altos, California · Equity, Options, Convertible · 172 investors · Kirsten Macfarlane, Ramtin Agah
Surrozen, Inc./DEBiotechnology
South San Francisco, California · founded 2021 · Equity, Options, Convertible · 18 investors · Mace Rothenberg, M.D., Craig Parker
Skylark Bio, Inc.Biotechnology
Cambridge, Massachusetts · founded 2021 · Equity · 2 investors · Steve Gillis, Giampiero De Luca
22nd Century Group, Inc.Biotechnology
Mocksville, North Carolina · Equity, Options · 9 investors · Daniel Otto, Lucille Salhany
Flagship Biosciences, Inc.Biotechnology
Broomfield, Colorado · Equity · 3 investors · Paul Kirchgraber, Trevor Johnson
ImmVue Therapeutics Inc.Biotechnology
Toronto, Ontario, Canada · Equity · 3 investors · David Moon, Jayan Nagendran
RheumaGen, Inc.Biotechnology
Denver, Colorado · founded 2022 · Equity · 3 investors · Ryan Hart, Bobak Mozayeni
Mach5 Therapeutics, Inc.Biotechnology
Atlanta, Georgia · founded 2023 · Equity · 7 investors · Patrick Crutcher, Justin DiMartino
Kubanda Cryotherapy, Inc.Biotechnology
Baltimore, Maryland · Options, Convertible, Simple Agreement for Future Equity · 15 investors · Yixin Hu, Bailey Surtees
RheumaGen, Inc.Biotechnology
Denver, Colorado · founded 2022 · Options, Convertible · 1 investors · Bruce Goodwin, James Hart, Jr.
ARC Medical Inc.Biotechnology
Richmond, British Columbia, Canada · Options, Convertible, Warrant exercisable for common shares of the Issuer, at no · 3 investors · Deng Mao, Bruce Hay
Life Adapt Inc.Biotechnology
San Clemente, California · founded 2023 · Equity · 1 investors · Lawrence Holder, Istvan Jonyer
Asher Biotherapeutics, Inc.Biotechnology
South San Francisco, California · founded 2019 · Equity · 16 investors · Craig Gibbs, Ivana Djuretic
Traws Pharma, Inc.Biotechnology
Newtown, Pennsylvania · Shares of Common Stock and Series C Preferred Stock · 2 investors · M. Shoemaker, Jack Stover
Outlook Therapeutics, Inc.Biotechnology
Iselin, New Jersey · Equity, Options, Convertible · 1 investors · Jeff Evanson, Julia Haller
Alphyn Biologics, Inc.Biotechnology
Annapolis, Maryland · founded 2019 · Equity · 18 investors · Neal Koller, Gary Pekoe
Bio-AI Health Inc.Biotechnology
Goffstown, New Hampshire · founded 2020 · Equity · 1 investors · Mike Vergato, Thomas Colarusso
Algorithm Sciences, Inc.Biotechnology
New York, New York · founded 2019 · Equity, Debt, Options · 2 investors · Michael Tilton, David Cavalier
Inomagen Therapeutics, Inc.Biotechnology
Chicago, Illinois · Equity, Options, Convertible · 4 investors · Rishi Arora, James Vogler